CILIATECH

CILIATECH is a biotech company in United Kingdom, founded in 2017. It has raised $3.9M across 1 round, most recently a $3.9M Series A in April 2023.

A New Class of Implant for Surgical Glaucoma

Employees
11–50
Founded
2017
Business Model
B2B
Website
cilia.tech
Total Funding
$3.9M
Last Round
$3.9M Series AApr 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Ciliatech is a pioneering French biotechnology company, founded in 2017, that is developing a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects. Its lead product, the Intercil Uveal Spacer, is a Cilioscleral Interpositioning Device that has been precision engineered to create a localised gap between the ciliary muscle and the sclera, working within the supraciliary space without needing to enter the eye's anterior chamber.

Summary

It lists 11–50 employees. It has raised $3.9M in total across 1 round, most recently a $3.9M Series A round in Apr 2023. Investors include KREAXI and BNP Paribas Développement.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2023
$3.9M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CILIATECH on Indexed.vc
<a href="https://indexed.vc/companies/ciliatech"><img src="https://indexed.vc/api/badge/company/ciliatech" alt="CILIATECH on Indexed.vc" width="260" height="76" /></a>